| Initial model | Final model | ||||
| RR | IC at 95% | p values | ARR | IC at 95% | p |
Gender |
|
| 0.0024 |
|
| 0.0053 |
Male | 1.00 |
|
| 1.00 |
|
|
Female | 2.43 | [1.38 - 4.38] |
| 1.97 | [1.23 - 3.19] |
|
Age (years) |
|
| 0.0002 |
|
| 0.0001 |
4 - 40 | 1.00 |
|
| 1.00 |
|
|
40 - 84 | 2.65 | [1.58 - 4.50] |
| 3.10 | [2.01 - 4.82] |
|
WHO clinical stage |
|
| 0.9565 |
|
|
|
1 | 1.00 |
|
|
|
|
|
2 | 0.94 | [0.50 - 1.77] |
|
|
|
|
3 | 1.00 | [0.46 - 2.20] |
|
|
|
|
4 | 0.78 | [0.31 - 1.92] |
|
|
|
|
CD4 count (/µl) |
|
| 0.2013 |
|
|
|
0 - 200 | 1.00 |
|
|
|
|
|
200 - 500 | 0.88 | [0.49 - 1.55] |
|
|
|
|
500 et plus | 0.45 | [0.18 - 1.08] |
|
|
|
|
Rate of hb (g/dl) |
|
| 0.3380 |
|
|
|
<12 | 0.58 | [0.46 - 0.74] |
| 1.00 |
|
|
≥12 | 0.57 | [0.44 - 0.72] |
|
|
|
|
Leukocytes (/mm3) |
|
| 0.0177 |
|
| 0.0016 |
<4000 | 1.00 |
|
| 1.00 |
|
|
4000 - 10,000 | 2.41 | [1.17 - 5.13] |
| 1.50 | [0.94 - 2.40] |
|
>10,000 | 5.33 | [1.36 - 21.97] |
| 5.13 | [2.06 - 13.82] |
|
Platelets (/mm3) |
|
|
|
|
|
|
<50,000 | 1.00 |
| 0.8943 |
|
|
|
≥50,000 | 0.64 | [0.20 - 1.84] |
|
|
|
|